30 October 2024
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Investor Presentation via Investor Meet Company.
Ananda Developments plc (AQSE: ANA), a Company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is pleased to announce that following the release of the Company's Interims Results, Melissa Sturgess will provide a live update presentation via Investor Meet Company on 15 Nov 2024, 12:30 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 Nov 2024, 09:00 GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Ananda Developments Plc via:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
Investors who already follow Ananda Developments Plc on the Investor Meet Company platform will automatically be invited.
-Ends-
To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:
· Investor Hub: investors.anandadevelopments.com
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
ANANDA DEVELOPMENTS PLC |
+44 (0)7463 686 497 |
|
ir@anandadevelopments.com |
Chief Executive Officer |
|
Melissa Sturgess |
|
|
|
Finance Director |
|
Jeremy Sturgess-Smith |
|
|
|
SP ANGEL CORPORATE FINANCE LLP |
+44 (0)20 3470 0470 |
|
|
Corporate Finance |
|
Richard Morrison |
|
|
|
|
|
Corporate Broking |
|
Abigail Wayne |
|
Rob Rees
|
|
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 ananda@yellowjerseypr.com |
About Ananda Developments
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions.
For more information, please visit: https://anandadevelopments.com
https://investors.anandadevelopments.com/link/drLkqe